| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.056 | 0.2 |